Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 12-England goes into new lockdown as COVID-19 variant rampages

Mon, 04th Jan 2021 07:57

* PM Johnson announces tougher restrictions

* Whole of England under "stay at home" order

* Lockdown to last until at least mid-February

* Earlier, UK began rollout of AstraZeneca vaccine
(Adds details)

By William Schomberg and Elizabeth Piper

LONDON, Jan 4 (Reuters) - British Prime Minister Boris
Johnson on Monday ordered England into a new national lockdown
to contain a surge in COVID-19 cases that threatens to overwhelm
parts of the health system before a vaccine programme reaches a
critical mass.

The announcement came just hours after the government hailed
Britain's success in becoming the first country to begin rolling
out the vaccine developed by Oxford University and AstraZeneca
against COVID-19.

Johnson said a new, more contagious variant of the
coronavirus first identified in the United Kingdom and now
present in many other countries was spreading at great speed and
immediate action was needed to slow it down.

"As I speak to you tonight, our hospitals are under more
pressure from COVID than any time since the start of the
pandemic," Johnson said in a televised address to the country.

"With most of the country already under extreme measures,
it's clear that we need to do more together to bring this new
variant under control," he said.

"We must therefore go into a national lockdown, which is
tough enough to contain this variant. That means the government
is once again instructing you to stay at home."

Non-essential shops and hospitality would have to remain
closed, while primary and secondary schools would close from
Tuesday for all pupils except vulnerable children and those
whose parents are key workers.

Johnson said the disruption meant it would not be possible
for all exams to go ahead this summer -- the second academic
year in a row in which the pandemic has played havoc with
pupils' education and future plans.

Johnson said that if the vaccine rollout went as planned and
the number of deaths responded to the lockdown measures as
expected, it should be possible to start moving out of lockdown
by the middle of February.

However, he urged caution about the timetable and appealed
to everyone to comply with the rules.

Britain's economy suffered a historic crash of nearly 20% in
the April-June period of 2020 as swathes of business were
shuttered by the first lockdown.

The new measures, which allow companies such as construction
firms to remain open, could cost about 10% of economic output
for as long as they last, said Julian Jessop, a fellow at the
Institute of Economic Affairs, a think-tank.

NEW VACCINE LAUNCHED

As Britain grapples with the world's sixth highest death
toll and cases hit a new high, the country's chief medical
officers said the spread of COVID-19 risked overwhelming parts
of the health system within 21 days.

The surge in cases has been driven by the new variant of
COVID-19, officials say, and while they acknowledge that the
pandemic is spreading more quickly than expected, they say there
is also light at the end of the tunnel - vaccinations.

Johnson's government earlier touted a scientific "triumph"
as Britain became the first country in the world to start
inoculating people with shots of the Oxford/AstraZeneca vaccine.

Dialysis patient Brian Pinker, 82, received the first
vaccination outside of a trial.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford," said
the retired maintenance manager, just a few hundred metres from
where the vaccine was developed.

But even with the vaccines being rolled out, the number of
COVID-19 cases and deaths keep rising.

More than 75,000 people in the United Kingdom have died from
COVID-19 within 28 days of a positive test since the start of
the pandemic. A record 58,784 new cases of the coronavirus were
reported on Monday.

Moving a few hours ahead of Johnson, Scottish First Minister
Nicola Sturgeon imposed the most stringent lockdown for Scotland
since last spring.

The devolved administration in Wales said all schools and
colleges there should move to online learning until Jan. 18.

(Additional reporting by Estelle Shirbon, Alistair Smout and
Guy Faulconbridge; Editing by Gareth Jones)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.